Egyptian businesswoman Hend El-Sherbini’s IDH posts $51.4-million revenue in H1 2024
IDH's core markets of Egypt and Jordan demonstrated strong performance, highlighting resilience despite regional challenges.
IDH's core markets of Egypt and Jordan demonstrated strong performance, highlighting resilience despite regional challenges.
El-Sherbini added that IDH’s core markets of Egypt and Jordan displayed strong growth, indicating further potential.
El-Sherbini owns a significant 26.71-percent stake in IDH — this translates to 160,250,305 ordinary shares in the company.
Billionaires.Africa has identified and cataloged various companies and holdings linked to El-Sherbini.
El-Sherbini owns a significant 26.71-percent stake in the company, or 160,250,305 ordinary shares.
El-Sherbini owns a significant 25.5-percent stake in Integrated Diagnostics Holdings.
El-Sherbini owns a significant 25.5-percent stake in Integrated Diagnostics Holdings.
Integrated Diagnostics Holdings is a renowned healthcare services provider.
IDH is a major consumer healthcare group in the Middle East and Africa.
El-Sherbini explained that the ramp-up strategy will create added value for IDH.
El-Sherbini controls a 26.1-percent stake in the group.
El-Sherbini controls a significant 26.1-percent stake in Integrated Diagnostics Holdings.
IDH is one of the Middle East and Africa’s leading consumer healthcare groups.
This is a quarter of the $70-million dividend approved by the board at the end of the 2021 financial year.
IDH is a leading consumer healthcare group in the Middle East and Africa.
El-Sherbini owns a 25.5-percent stake in the group, or 152,982,356 ordinary shares.